Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0EZLTJ
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
h1F6-22 MMAF
|
|||||
| Synonyms |
h1F6-22-MMAF
Click to Show/Hide
|
|||||
| Organization |
Seagen Inc.
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 2 Indication(s)
B-cell lymphoma [ICD11:2A86]
Investigative
Renal cell carcinoma [ICD11:2C90]
Investigative
|
|||||
| Drug-to-Antibody Ratio |
8
|
|||||
| Antibody Name |
Vorsetuzumab
|
Antibody Info | ||||
| Antigen Name |
CD70 antigen (CD70)
|
Antigen Info | ||||
| Payload Name |
Monomethyl auristatin F
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
ValoH-AlaGlu-Dpr-MDpr
|
Linker Info | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.